Cancer Risk
Showing 9-15 of 15 results
Research roundup: June 2023 edition
Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.
Jun 30, 2023
Research roundup: April 2023 edition
Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.
Apr 28, 2023
Research roundup: July 2021 edition
Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.
Jul 30, 2021
Research roundup: June 2021 edition
In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.
Jun 30, 2021
Research roundup: August 2020 edition
The benefit of ultrasound guidance in IUD placement for patients with retroverted uteri, a demonstrated need for trauma-informed care in sexually-transmitted disease clinics, demand among abortion patients for more autonomous care options, and more.
Aug 31, 2020
Research roundup: September 2019 edition
An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.
Sep 30, 2019
What does evidence say about combined vs. progestin-only pills?
COCs or POPs? Here are some things to consider when helping a patient pick a pill.
Feb 9, 2016
- 1
- 2(current)
Join Bedsider Providers+
Stay on top of SRH policy, mis/disinformation, clinical information and research - all in one place. Members help sustain tools young people rely on, including Bedsider.
Starting at $8/month. Cancel anytime.